Protagenic Therapeutics, Inc.\new (PTIX) Operating income 2018–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual operating income history from SEC filings — each fiscal year as reported.
-$4.5MFY2026 · since FY2018: -$2.4M → -$4.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.5M | -73.6% |
| FY2025 | -$2.6M | +42.7% |
| FY2024 | -$4.5M | -27.2% |
| FY2023 | -$3.6M | +14.1% |
| FY2022 | -$4.1M | -62.3% |
| FY2021 | -$2.6M | -22.3% |
| FY2020 | -$2.1M | +9.9% |
| FY2019 | -$2.3M | +2.2% |
| FY2018 | -$2.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice